Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Eur J Dermatol ; 13(5): 505-8, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14693502

RESUMO

We report a sporadic case of eruptive milia with histopathological features of basaloid follicular hamartoma which developed in an 8 year-old Japanese girl. Multiple milia and comedo-like eruptions were present at birth and gradually increased in number and spread over the extremities. Histopathologically, keratotic cysts with trichilemmal keratinization and features of basaloid follicular hamartoma were observed without any histological findings of basal cell epithelioma or trichoepithelioma. Reduced sweating was observed after iontophoretically applied acetylcholine on the forearm. Nevus of Ota and thyroid goiter were complications.


Assuntos
Hamartoma/complicações , Hipo-Hidrose/complicações , Miliária/complicações , Dermatopatias/complicações , Criança , Face , Feminino , Bócio/complicações , Hamartoma/patologia , Humanos , Miliária/patologia , Nevo de Ota/complicações , Dermatopatias/patologia
2.
Eur J Dermatol ; 13(4): 372-6, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12948918

RESUMO

Vitiligo vulgaris is a common skin disease, however some cases show poor clinical responses to topical steroid ointment or PUVA therapy. Such regimens are generally avoided in the treatment of facial lesions or in pediatric cases because of the undesirable side effects. To confirm the excellent response to combination therapy with topical vitamin D3 ointment and solar irradiation for vitiligo achieved in the initial patients, we conducted an open trial on other patients, most of whom had poor clinical responses to the prior therapies. Fifteen patients (9 men and 6 women) with vitiligo vulgaris were enrolled in this study. Each patient was instructed to sunbathe for 30 minutes within 1 hour after topical application of the tacalcitol [1 alpha 24(OH)(2)D(3)] ointment or cream to the skin lesions every day. Six of 15 patients showed a fair and excellent clinical response to the combination therapy (more than 30% clearance of the vitiligo). The clinical effect was more apparent in patients with a history of less than 5 years of vitiligo (4 of 6 cases) in contrast to those with a history of more than 5 years (2 of 9 cases). In vitro experiments revealed that tacalcitol upregulated the expression of c-Kit mRNA by melanocytes irradiated with linear polarized infrared, UVA or short period solar irradiation. These results suggest that combination therapy with topical vitamin D(3) ointment and solar irradiation can be used as an alternate therapy for vitiligo vulgaris.


Assuntos
Fármacos Dermatológicos/administração & dosagem , Di-Hidroxicolecalciferóis/administração & dosagem , Proteínas Proto-Oncogênicas c-kit/efeitos dos fármacos , RNA Mensageiro/análise , Luz Solar , Vitiligo/tratamento farmacológico , Administração Cutânea , Adulto , Idoso , Células Cultivadas , Criança , Fármacos Dermatológicos/farmacologia , Di-Hidroxicolecalciferóis/farmacologia , Pálpebras , Feminino , Humanos , Masculino , Melanócitos/efeitos dos fármacos , Melanócitos/metabolismo , Pessoa de Meia-Idade , Pomadas , Proteínas Proto-Oncogênicas c-kit/genética , Resultado do Tratamento , Regulação para Cima , Vitiligo/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA